Angiopoietin-like-4 (Angptl4) is a potent inhibitor of lipoprotein lipase[6] and induces marked hypertriglyceridemia after intravenous injection or adenovirus-mediated expression[7]. This evidence concerns the gene ANGPTL4 and hypertriglyceridemia.